(株)サイフューズの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4892/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/02/07 | 日証協 | 698,400株 | -6.04% | 130,100株 | +175.64% | 1,000,105株 | +1.79% | 26,900株 | +2.67% |
2025/01/31 | 日証協 | 743,300株 | +2.71% | 47,200株 | +108.85% | 982,505株 | +0.32% | 26,200株 | +164.65% |
2025/01/24 | 日証協 | 723,700株 | -1.13% | 22,600株 | -10.32% | 979,405株 | -0.84% | 9,900株 | -35.14% |
2025/01/17 | 日証協 | 732,000株 | 0% | 25,200株 | -67.77% | 987,675株 | -0.35% | 15,264株 | -77.33% |
2025/01/10 | 日証協 | 732,000株 | +3.46% | 78,200株 | 0% | 991,111株 | +8.53% | 67,345株 | +2004.53% |
2024/12/30 | 日証協 | 707,500株 | -8.38% | 0株 | -100% | 913,255株 | -6.38% | 3,200株 | -96.9% |
2024/12/27 | 日証協 | 772,200株 | +20.94% | 111,500株 | +47.88% | 975,482株 | +9.2% | 103,112株 | +8.63% |
2024/12/20 | 日証協 | 638,500株 | -1.36% | 75,400株 | -74.37% | 893,272株 | -0.68% | 94,920株 | +54.85% |
2024/12/13 | 日証協 | 647,300株 | +33.82% | 294,200株 | +29.04% | 899,362株 | +5.19% | 61,300株 | -58.16% |
2024/12/06 | 日証協 | 483,700株 | -8.36% | 228,000株 | +4045.45% | 854,960株 | -2.84% | 146,513株 | +1827.8% |
2024/11/29 | 日証協 | 527,800株 | -17.44% | 5,500株 | -91.75% | 879,959株 | -6.51% | 7,600株 | -84.77% |
2024/11/22 | 日証協 | 639,300株 | -4.89% | 66,700株 | -32.49% | 941,259株 | -2.44% | 49,900株 | -11.68% |
2024/11/15 | 日証協 | 672,200株 | +6.82% | 98,800株 | +2370% | 964,760株 | -0.45% | 56,500株 | +520.88% |
2024/11/08 | 日証協 | 629,300株 | -10.38% | 4,000株 | -92.77% | 969,160株 | -0.81% | 9,100株 | -13.33% |
2024/11/01 | 日証協 | 702,200株 | -12.37% | 55,300株 | -64.73% | 977,060株 | -4.59% | 10,500株 | -79.81% |
2024/10/25 | 日証協 | 801,300株 | -2.13% | 156,800株 | -2.49% | 1,024,060株 | -0.99% | 52,000株 | +477.78% |
2024/10/18 | 日証協 | 818,700株 | +0.81% | 160,800株 | -5.63% | 1,034,260株 | +0.61% | 9,000株 | -68.98% |
2024/10/11 | 日証協 | 812,100株 | -1.4% | 170,400株 | -48.03% | 1,027,960株 | +0.5% | 29,012株 | -68.84% |
2024/10/04 | 日証協 | 823,600株 | +23.48% | 327,900株 | +293.64% | 1,022,848株 | +7.59% | 93,100株 | +325.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top